IBDEI1WH ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,30344,2)
 ;;=^5003400
 ;;^UTILITY(U,$J,358.3,30345,0)
 ;;=F18.959^^120^1545^15
 ;;^UTILITY(U,$J,358.3,30345,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30345,1,3,0)
 ;;=3^Inhalant Induced Psychotic D/O w/o Use D/O
 ;;^UTILITY(U,$J,358.3,30345,1,4,0)
 ;;=4^F18.959
 ;;^UTILITY(U,$J,358.3,30345,2)
 ;;=^5003412
 ;;^UTILITY(U,$J,358.3,30346,0)
 ;;=F18.99^^120^1545^22
 ;;^UTILITY(U,$J,358.3,30346,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30346,1,3,0)
 ;;=3^Inhalant Related D/O,Unspec
 ;;^UTILITY(U,$J,358.3,30346,1,4,0)
 ;;=4^F18.99
 ;;^UTILITY(U,$J,358.3,30346,2)
 ;;=^5133360
 ;;^UTILITY(U,$J,358.3,30347,0)
 ;;=F18.21^^120^1545^25
 ;;^UTILITY(U,$J,358.3,30347,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30347,1,3,0)
 ;;=3^Inhalant Use D/O,Mod/Sev,In Remission
 ;;^UTILITY(U,$J,358.3,30347,1,4,0)
 ;;=4^F18.21
 ;;^UTILITY(U,$J,358.3,30347,2)
 ;;=^5003393
 ;;^UTILITY(U,$J,358.3,30348,0)
 ;;=F18.11^^120^1545^24
 ;;^UTILITY(U,$J,358.3,30348,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30348,1,3,0)
 ;;=3^Inhalant Use D/O,Mild,In Remission
 ;;^UTILITY(U,$J,358.3,30348,1,4,0)
 ;;=4^F18.11
 ;;^UTILITY(U,$J,358.3,30348,2)
 ;;=^5151305
 ;;^UTILITY(U,$J,358.3,30349,0)
 ;;=Z00.6^^120^1546^1
 ;;^UTILITY(U,$J,358.3,30349,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30349,1,3,0)
 ;;=3^Exam Control in Clinical Research
 ;;^UTILITY(U,$J,358.3,30349,1,4,0)
 ;;=4^Z00.6
 ;;^UTILITY(U,$J,358.3,30349,2)
 ;;=^5062608
 ;;^UTILITY(U,$J,358.3,30350,0)
 ;;=F45.8^^120^1547^13
 ;;^UTILITY(U,$J,358.3,30350,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30350,1,3,0)
 ;;=3^Somatoform Symp & Rel D/O,Oth Spec
 ;;^UTILITY(U,$J,358.3,30350,1,4,0)
 ;;=4^F45.8
 ;;^UTILITY(U,$J,358.3,30350,2)
 ;;=^331915
 ;;^UTILITY(U,$J,358.3,30351,0)
 ;;=F45.0^^120^1547^12
 ;;^UTILITY(U,$J,358.3,30351,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30351,1,3,0)
 ;;=3^Somatization D/O
 ;;^UTILITY(U,$J,358.3,30351,1,4,0)
 ;;=4^F45.0
 ;;^UTILITY(U,$J,358.3,30351,2)
 ;;=^112280
 ;;^UTILITY(U,$J,358.3,30352,0)
 ;;=F45.9^^120^1547^14
 ;;^UTILITY(U,$J,358.3,30352,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30352,1,3,0)
 ;;=3^Somatoform Symp & Rel D/O,Unspec
 ;;^UTILITY(U,$J,358.3,30352,1,4,0)
 ;;=4^F45.9
 ;;^UTILITY(U,$J,358.3,30352,2)
 ;;=^5003592
 ;;^UTILITY(U,$J,358.3,30353,0)
 ;;=F45.1^^120^1547^11
 ;;^UTILITY(U,$J,358.3,30353,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30353,1,3,0)
 ;;=3^Somatic Symptom D/O
 ;;^UTILITY(U,$J,358.3,30353,1,4,0)
 ;;=4^F45.1
 ;;^UTILITY(U,$J,358.3,30353,2)
 ;;=^5003585
 ;;^UTILITY(U,$J,358.3,30354,0)
 ;;=F44.4^^120^1547^4
 ;;^UTILITY(U,$J,358.3,30354,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30354,1,3,0)
 ;;=3^Conversion D/O w/ Motor Symp or Deficit
 ;;^UTILITY(U,$J,358.3,30354,1,4,0)
 ;;=4^F44.4
 ;;^UTILITY(U,$J,358.3,30354,2)
 ;;=^5003579
 ;;^UTILITY(U,$J,358.3,30355,0)
 ;;=F44.6^^120^1547^1
 ;;^UTILITY(U,$J,358.3,30355,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30355,1,3,0)
 ;;=3^Conversion D/O w/ Anesthesia or Sensory Loss
 ;;^UTILITY(U,$J,358.3,30355,1,4,0)
 ;;=4^F44.6
 ;;^UTILITY(U,$J,358.3,30355,2)
 ;;=^5003581
 ;;^UTILITY(U,$J,358.3,30356,0)
 ;;=F44.5^^120^1547^2
 ;;^UTILITY(U,$J,358.3,30356,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30356,1,3,0)
 ;;=3^Conversion D/O w/ Attacks or Seizures
 ;;^UTILITY(U,$J,358.3,30356,1,4,0)
 ;;=4^F44.5
 ;;^UTILITY(U,$J,358.3,30356,2)
 ;;=^5003580
 ;;^UTILITY(U,$J,358.3,30357,0)
 ;;=F44.7^^120^1547^3
